RENAISSANCE TECHNOLOGIES LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1037389 NEW YORK, NY

Position in KRYS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$22,181,265

+$19,701,393 QoQ

Shares Held

59,680

+521.7% QoQ

Ownership

0.202%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#50

of 419 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,560,012 across 312 Biotechnology names. KRYS ranks #34 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,181,265	59,680	+521.7%	Shares	Sole	2026-08-13
2026-03-31	$2,479,872	9,600	+190.9%	Shares	Sole	2026-05-14
2025-12-31	$813,582	3,300	-96.3%	Shares	Sole	2026-02-12
2025-06-30	$12,343,908	89,800	+701.8%	Shares	Sole	2025-08-13
2025-03-31	$2,019,360	11,200	+2.8%	Shares	Sole	2025-05-14
2024-12-31	$1,707,594	10,900	-24.3%	Shares	Sole	2025-02-13
2024-09-30	$2,621,232	14,400	-41.7%	Shares	Sole	2024-11-13
2024-03-31	$4,394,871	24,700	-25.8%	Shares	Sole	2024-05-13
2021-09-30	$1,738,593	33,300	+69.9%	Shares	Sole	2021-11-12
2020-09-30	$843,780	19,600	-68.1%	Shares	Sole	2020-11-13
2020-06-30	$2,543,188	61,400	+923.3%	Shares	Sole	2020-08-13
2020-03-31	$259,440	6,000	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.